Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers
Status:
Completed
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
This single-center study will be conducted in 3 phases: a single-ascending dose phase (up to
8 cohorts, 8 subjects/cohort), a multiple-dose phase (up to 5 cohorts, 9 subjects/cohort),
and a midazolam drug-drug interaction phase (one cohort of 8 subjects).